Annual Total Liabilities
$44.06 M
+$3.48 M+8.58%
December 31, 2024
Summary
- As of March 13, 2025, PRLD annual total liabilities is $44.06 million, with the most recent change of +$3.48 million (+8.58%) on December 31, 2024.
- During the last 3 years, PRLD annual total liabilities has risen by +$24.86 million (+129.45%).
- PRLD annual total liabilities is now -38.20% below its all-time high of $71.28 million, reached on December 31, 2019.
Performance
PRLD Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$44.06 M
+$3.27 M+8.01%
December 31, 2024
Summary
- As of March 13, 2025, PRLD quarterly total liabilities is $44.06 million, with the most recent change of +$3.27 million (+8.01%) on December 31, 2024.
- Over the past year, PRLD quarterly total liabilities has increased by +$3.27 million (+8.01%).
- PRLD quarterly total liabilities is now -56.83% below its all-time high of $102.06 million, reached on June 30, 2020.
Performance
PRLD Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PRLD Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.6% | +8.0% |
| 3 y3 years | +129.4% | +75.8% |
| 5 y5 years | -38.2% | +75.8% |
PRLD Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.4% | at high | +141.9% |
| 5 y | 5-year | -38.2% | +286.2% | -56.8% | +287.3% |
| alltime | all time | -38.2% | +286.2% | -56.8% | +287.3% |
Prelude Therapeutics Incorporated Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $44.06 M(+8.6%) | $44.06 M(+8.0%) |
| Sep 2024 | - | $40.79 M(-2.9%) |
| Jun 2024 | - | $42.02 M(+15.5%) |
| Mar 2024 | - | $36.37 M(-10.4%) |
| Dec 2023 | $40.58 M(+61.9%) | $40.58 M(+100.3%) |
| Sep 2023 | - | $20.25 M(+9.2%) |
| Jun 2023 | - | $18.55 M(-19.4%) |
| Mar 2023 | - | $23.02 M(-8.1%) |
| Dec 2022 | $25.06 M | $25.06 M(+0.6%) |
| Sep 2022 | - | $24.92 M(+36.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $18.21 M(-3.4%) |
| Mar 2022 | - | $18.86 M(-1.8%) |
| Dec 2021 | $19.20 M(+68.3%) | $19.20 M(-3.9%) |
| Sep 2021 | - | $19.98 M(+31.2%) |
| Jun 2021 | - | $15.22 M(+14.7%) |
| Mar 2021 | - | $13.26 M(+16.3%) |
| Dec 2020 | $11.41 M(-84.0%) | $11.41 M(+0.3%) |
| Sep 2020 | - | $11.37 M(-88.9%) |
| Jun 2020 | - | $102.06 M(+43.2%) |
| Dec 2019 | $71.28 M(+82.3%) | $71.28 M |
| Dec 2018 | $39.10 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual total liabilities?
- What is the all time high annual total liabilities for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual total liabilities year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly total liabilities?
- What is the all time high quarterly total liabilities for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly total liabilities year-on-year change?
What is Prelude Therapeutics Incorporated annual total liabilities?
The current annual total liabilities of PRLD is $44.06 M
What is the all time high annual total liabilities for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual total liabilities is $71.28 M
What is Prelude Therapeutics Incorporated annual total liabilities year-on-year change?
Over the past year, PRLD annual total liabilities has changed by +$3.48 M (+8.58%)
What is Prelude Therapeutics Incorporated quarterly total liabilities?
The current quarterly total liabilities of PRLD is $44.06 M
What is the all time high quarterly total liabilities for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly total liabilities is $102.06 M
What is Prelude Therapeutics Incorporated quarterly total liabilities year-on-year change?
Over the past year, PRLD quarterly total liabilities has changed by +$3.27 M (+8.01%)